title: The European Heart Rhythm Association Practical Guide on the Use of New Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation - A Brief Summary.
abstract: New oral anticoagulants (NOACs) are an alternative to vitamin K antagonists (VKAs) in the prevention of stroke in patients with non-valvular atrial fibrillation (AF). The European Heart Rhythm Association (EHRA) has produced a practical guide to detail the use of NOACs in clinical practice. The guide includes a practical start-up and follow-up scheme, emphasising the importance of strict adherence to the regimen - the anticoagulant effect drops rapidly after 12-24 hours. There is also guidance on how to measure the anticoagulant effect of NOACs, switching between anticoagulant regimes and dealing with dosing errors. Physicians will have to consider the pharmacokinetic effect of drugs and co-morbidities when prescribing NOACs - plasma levels of NOACs may be affected by P-glycoprotein (P-gp) substrates, as well as cytochrome P450 (CYP3A4) inducers or inhibitors. In patients with chronic kidney disease, reduced doses of NOACs may be indicated. Guidance is also given on the management of bleeding complications, and the cessation and reinitiation of NOACs in patients undergoing surgical interventions. Finally, the use of NOACs in specific clinical situations is considered; these include patients with AF and coronary artery disease (CAD), patients presenting with acute stroke while taking NOACs and patients with cancer.
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, Birmingham, UK.
authors.forename: Paulus
authors.initials: P
authors.lastname: Kirchhof
keywords: Atrial fibrillation; apixaban; dabigatran; edoxaban; new oral anticoagulants; rivaroxaban
references.citation: Circulation. 2011 Jan 18;123(2):131-6
references.pmid: 21200007
references.citation: J Thromb Haemost. 2011 Sep;9(9):1705-12
references.pmid: 21729240
references.citation: Eur Heart J. 2012 Sep;33(17):2163-71
references.pmid: 22752615
references.citation: Circulation. 2013 Sep 10;128(11):e172-3
references.pmid: 24019452
references.citation: Europace. 2013 May;15(5):625-51
references.pmid: 23625942
references.citation: Br J Haematol. 2003 Nov;123(4):676-82
references.pmid: 14616972
references.citation: Clin Pharmacokinet. 2011 Oct;50(10):675-86
references.pmid: 21895039
references.citation: Clin Pharmacokinet. 2010 Apr;49(4):259-68
references.pmid: 20214409
references.citation: Eur Heart J. 2012 Nov;33(21):2692-9
references.pmid: 22453654
references.citation: Adv Ther. 2012 Aug;29(8):675-90
references.pmid: 22898791
references.citation: Am Heart J. 2010 Oct;160(4):635-41
references.pmid: 20934556
references.citation: Eur Heart J. 2011 Dec;32(23):2999-3054
references.pmid: 21873419
references.citation: J Pharmacol Exp Ther. 2011 Jul;338(1):372-80
references.pmid: 21515813
references.citation: N Engl J Med. 2011 Mar 3;364(9):806-17
references.pmid: 21309657
references.citation: N Engl J Med. 2009 Sep 17;361(12):1139-51
references.pmid: 19717844
references.citation: Eur Heart J. 2012 Nov;33(22):2821-30
references.pmid: 22933567
references.citation: Heart. 2008 Jul;94(7):867-73
references.pmid: 18332062
references.citation: Drug Metab Dispos. 2010 Mar;38(3):448-58
references.pmid: 19940026
references.citation: N Engl J Med. 2012 Aug 16;367(7):625-35
references.pmid: 22894575
references.citation: Eur Heart J. 2012 Nov;33(21):2719-47
references.pmid: 22922413
references.citation: J Am Coll Cardiol. 2012 Mar 27;59(13):1168-74
references.pmid: 22305113
references.citation: Circulation. 2012 Feb 7;125(5):669-76
references.pmid: 22215856
references.citation: Europace. 2010 Oct;12(10):1360-420
references.pmid: 20876603
references.citation: Thromb Haemost. 2012 May;107(5):838-47
references.pmid: 22318514
references.citation: Eur Heart J. 2011 Oct;32(19):2387-94
references.pmid: 21873708
references.citation: Br J Clin Pharmacol. 2013 Sep;76(3):455-66
references.pmid: 23305158
references.citation: Am J Med. 2012 Apr;125(4):417-20
references.pmid: 22306274
references.citation: N Engl J Med. 2011 Sep 8;365(10):883-91
references.pmid: 21830957